GlassScriptPhysician profile
Anh D Vu
NPI 1023050010
$1,941.84
in general payments reported to CMS, 2019-2025
27 companies · $738 in 2025
The $738 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $13.83 · 2021: $233 · 2022: $57.30 · 2023: $395 · 2024: $298 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $421.90 | 2023-2025 | Extended Holter, (5044) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.02 | 2019-2025 | Lifevest |
| Abbott Laboratories | $182.69 | 2021-2023 | Confirm Rx |
| Amgen INC. | $164.61 | 2022-2025 | Repatha, Repatha |
| Medtronic, INC. | $163.71 | 2021-2023 | Micra |
| Akcea Therapeutics, INC. | $126.39 | 2019 | |
| Edwards Lifesciences Corporation | $117.78 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $93.50 | 2025 | |
| Novartis Pharmaceuticals Corporation | $52.35 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $47.11 | 2019-2024 | Xarelto |
| Cardiva Medical, INC. | $41.69 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $38.18 | 2025 | |
| Atricure, INC. | $37.73 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Astrazeneca Pharmaceuticals LP | $36.80 | 2022-2025 | Wainua |
| Cvrx, INC. | $30.50 | 2025 | Barostim Neo System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $26.35 | 2025 | Assure Wcd |
| Zoll Circulation INC | $24.83 | 2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Heartflow, INC. | $22.16 | 2025 | |
| Azurity Pharmaceuticals, INC. | $14.20 | 2024 | Edarbyclor |
| Encore Dermatology INC. | $13.83 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.48 | 2024 | Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $13.36 | 2024 | Arcalyst |
| Boston Scientific Corporation | $13.23 | 2024 | Watchman Access System |
| Merck Sharp & Dohme LLC | $13.13 | 2024 | Verquvo |
| Portola Pharmaceuticals, LLC | $12.28 | 2019 | |
| Altathera Pharmaceuticals LLC | $9.59 | 2024 | Sotalol Hydrochloride |
| Biofrontera INC. | $4.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anh Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.